Advanced search
Publication Cover
Expert Opinion on Medical Diagnostics Volume 2, 2008 - Issue 1
Journal homepage
78
Views
7
CrossRef citations to date
0
Altmetric
Review

Biomarkers for Huntington's disease

Edward J Wild UCL Institute of Neurology, Department of Neurodegenerative Disease, Queen Square, London WC1N 3BG, UK +44 8451 555 000; +44 207 676 2180; [email protected]
, MRCP &
Sarah J Tabrizi UCL Institute of Neurology, Department of Neurodegenerative Disease, Queen Square, London WC1N 3BG, UK +44 8451 555 000; +44 207 676 2180; [email protected]
, FRCP PhD
Pages 47-62 | Published online: 07 Jan 2008

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Edward Wild, Maria Björkqvist & Sarah J Tabrizi. (2008) Immune markers for Huntington’s disease?. Expert Review of Neurotherapeutics 8:12, pages 1779-1781.
Read now

Articles from other publishers (6)

Lauren M. Byrne & Edward J. Wild. (2016) Cerebrospinal Fluid Biomarkers for Huntington’s Disease. Journal of Huntington's Disease 5:1, pages 1-13.
Crossref
Christopher A. Ross, Elizabeth H. Aylward, Edward J. Wild, Douglas R. Langbehn, Jeffrey D. Long, John H. Warner, Rachael I. Scahill, Blair R. Leavitt, Julie C. Stout, Jane S. Paulsen, Ralf Reilmann, Paul G. Unschuld, Alice Wexler, Russell L. Margolis & Sarah J. Tabrizi. (2014) Huntington disease: natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology 10:4, pages 204-216.
Crossref
. 2013. Metal-based Neurodegeneration. Metal-based Neurodegeneration 337 394 .
Nicholas WoodEdward J. Wild & Sarah J. Tabrizi. 2012. Neurogenetics. Neurogenetics 64 82 .
Christopher A Ross & Sarah J Tabrizi. (2011) Huntington's disease: from molecular pathogenesis to clinical treatment. The Lancet Neurology 10:1, pages 83-98.
Crossref
Edward J. Wild, Susie M.D. Henley, Nicola Z. Hobbs, Chris Frost, David G. MacManus, Roger A. Barker, Nick C. Fox & Sarah J. Tabrizi. (2010) Rate and acceleration of whole-brain atrophy in premanifest and early Huntington's disease. Movement Disorders 25:7, pages 888-895.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.